Teclistamab-Daratumumab in AL Amyloidosis

NCT07110844 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Amyloid Light-chain Amyloidosis

Interventions

DRUG: Teclistamab
DRUG: Daratumumab and Hyaluronidase-fihj

Sponsor

Suzanne Lentzsch, MD

Collaborators

[object Object]